Xeris Pharmaceuticals | XERS - EPS Earnings Per Share



Xeris Pharmaceuticals reported $-0.01 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
-0.01 -0.03 Aug/07 2025


Eps Change Date
Adcock Ingram Holdings ZAR 2.59 0.17 Dec/2024
Celltrion KRW 810.39 301.74 Jun/2025
Cspc Pharmaceutical CNY 0.13 0.08 Mar/2025
Dianthus Therapeutics USD -0.88 0.07 Jun/2025
Divis Laboratories Ltd 20.49 4.26 Jun/2025
Eli Lilly USD 6.31 2.97 Jun/2025
Kangmei Pharma CNY 0 0 Jun/2025
Knight Therapeutics CAD 0 0.02 Sep/2024
Laboratorios Farma 0.42 1.39 Jun/2025
Malin Corporation 0 0 Dec/2024
Medical Developments International AUD 0 0.34 Dec/2024
Neuren Pharmaceuticals AUD 1.02 0.96 Dec/2024
Organigram Holdings CAD -0.05 0.16 Jun/2025
Pacira USD 0.74 0.12 Jun/2025
Perrigo USD 0.57 0.03 Jun/2025
Pharma Mar EUR 1.32 1.55 Jun/2025
Qiagen NV USD 0.6 0.12 Jun/2025
Sartorius EUR 0.47 0.75 Jun/2025
Sino Biopharmaceutical CNY 0.19 0.16 Jun/2025
Supernus Pharmaceuticals USD 0.4 0.61 Jun/2025
Tilray USD -1.78 0.54 Jun/2025
Zhangzhou Pientzehuang Pharmaceutical 0.73 0.93 Jun/2025